Avantor Clinical Services helps clinical trials stay on track
September 15, 2020Manufacturing and Production
Biopharma and pharmaceutical companies developing treatments and vaccines have long faced operational challenges that cost time and money while draining …
Oncology research in the age of COVID-19
September 14, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma
Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review
September 14, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine
After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …
Gilead scoops up Immunomedics in deal worth $21 billion
September 14, 2020Sales and Marketing Gilead, Immunomedics, acquisition, pharma
The Board of Directors from both companies have unanimously agreed for Gilead to acquire Immunomedics for $88 per share in …
World Health Organization reports highest one-day rise in COVID-19 infections
September 14, 2020Sales and Marketing WHO, coronavirus
The World Health Organization has recorded the largest daily rise of coronavirus infection worldwide since the pandemic began. This was …
Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by October
September 14, 2020Sales and Marketing Pfizer, Pfizer vaccine, Vaccine
Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …
Trump signs order to start a process to lower US drug prices
September 14, 2020Sales and Marketing Donald Trump drug prices, drug prices
President Trump has signed an executive order that could cut drug prices by tying them to similar prices in countries …
Targazyme snaps up new CEO
September 11, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targazyme, appointment
Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …
NICE U-turns to approve AstraZeneca’s Tagrisso in two new lung cancer indications
September 11, 2020Medical Communications, Sales and Marketing AstraZeneca, NICE, Tagrisso
NICE has announced the recommendation of AstraZeneca’s Tagrisso (osimertinib) for routine use on the NHS in England and Wales in …
Roche and Novartis fined a collective €444 million in France for abusive practices
September 11, 2020Medical Communications eye medicine, eye treatment
Novartis and Roche have been fined €444 million in France for abusive practices the companies implemented to push Lucentis over …
NICE opts to reject Celgene’s Revlimid for newly diagnosed multiple myeloma after an autologous stem cell transplant
September 11, 2020Medical Communications, Sales and Marketing Celgene, NICE, Revlimid
It has emerged that NICE has opted to reject Celgene’s Revlimid (lenalidomide) for the maintenance of newly diagnosed multiple myeloma …
FDA sends warning letters to websites illegally selling opioids
September 11, 2020Medical Communications
The FDA has issued warning letters to 17 websites for illegally selling unapproved or misbranded opioids. This is due to …
Top Ten most popular articles on Pharmafile.com this week
September 11, 2020Medical Communications COVID-19, coronavirus, vaccines
The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …
FDA approves GlaxoSmithKline’s Trelegy for treating asthma
September 10, 2020Research and Development Ashtma, inhaler
The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive …
AstraZeneca Chief Executive says vaccine is still possible this year
September 10, 2020Research and Development AstraZeneca, Oxford Vaccine, Vaccine, coronavirus vaccine, vaccines
Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical …
Pfizer-BioNTech reports strong immune response in animals to its COVID-19 vaccine
September 10, 2020Research and Development COVID, Macaques, Monkey, Vaccine
Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its …
President Trump has misled the public on how deadly COVID-19 is, according to Watergate reporter’s tapes
September 10, 2020Medical Communications All the President's men, Bob Woodward, Trump, Watergate
President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of …
Pharmafile.com’s weekly COVID-19 news round-up
September 10, 2020Business Services
The coronavirus news this week focuses on lockdowns and infections, as England is set to increase lockdown restrictions across the …
Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO
September 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments
Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …
Ali Fattaey appointed Chief Executive Officer of MetaboMed
September 9, 2020Research and Development
MetaboMed has appointed Ali Fattaey, Ph.D. as its new Chief Executive Officer.Fattaey has over 20 years experience in the industry. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
